Rig-I/DDX58 Recombinant Rabbit mAb (S-1419-114)
Antiviral innate immune response receptor RIG-I,ATP-dependent RNA helicase DDX58,DEAD box protein 58,RIG-I-like receptor 1 (RLR-1),RNA sensor RIG-I,Retinoic acid-inducible gene 1 protein (RIG-1),Retinoic acid-inducible gene I protein (RIG-I),DDX58,RIGI
产品介绍 FAQs 评论(0)
宿主来源
Rabbit抗原名称
Rig-I/DDX58分子别名
Antiviral innate immune response receptor RIG-I; ATP-dependent RNA helicase DDX58; DEAD box protein 58; RIG-I-like receptor 1 (RLR-1); RNA sensor RIG-I; Retinoic acid-inducible gene 1 protein (RIG-1); Retinoic acid-inducible gene I protein (RIG-I); DDX58; RIGI免疫原
Synthetic Peptide细胞定位
Cytoplasm, Cell junctionAccession
O95786克隆号
S-1419-114抗体类型
Recombinant mAb抗体同种型
IgG反应种属 ?
Hu, Ms纯化方式
Protein A浓度
0.5 mg/ml标记
Unconjugated性状
Liquid缓冲体系
PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
储存条件
12 months from date of receipt / reconstitution, -20 °C as supplied
应用
WB
稀释度
应用 稀释度 推荐种属 WB 1:1000 Hu, Ms
Rig-I (Retinoic acid-inducible gene I) is a crucial cytosolic pattern recognition receptor (PRR) in the innate immune system, belonging to the DExD/H-box RNA helicase family. It primarily detects viral RNA, such as short double-stranded RNA (dsRNA) with a 5'-triphosphate group (5'-ppp) or single-stranded RNA (ssRNA) with short stem-loop structures, thereby triggering antiviral immune responses. Structurally, Rig-I consists of two N-terminal tandem CARD domains (for signal transduction), a central DExD/H-box helicase domain (responsible for RNA binding and ATP hydrolysis), and a C-terminal regulatory domain (CTD, which specifically recognizes viral RNA). Upon binding viral RNA, Rig-I interacts with the mitochondrial antiviral signaling protein (MAVS) via its CARD domains, activating the IRF3/7 and NF-κB pathways to induce the production of type I interferons and pro-inflammatory cytokines. This protein plays a central role in defending against RNA viruses (e.g., influenza virus, hepatitis C virus), and its dysfunction is closely associated with autoimmune diseases and increased susceptibility to viral infections.
免疫印迹
WB result of Rig-I/DDX58 Recombinant Rabbit mAb
Primary antibody: Rig-I/DDX58 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated THP-1 whole cell lysate 20 µg
Lane 2: THP-1 treated with 50 nM PMA and 5 µg/ml LPS for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 102 kDa
Observed MW: 110 kDaWB result of Rig-I/DDX58 Recombinant Rabbit mAb
Primary antibody: Rig-I/DDX58 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated RAW264.7 whole cell lysate 20 µg
Lane 2: RAW264.7 treated with 0.1 µg/ml LPS for 6 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 102 kDa
Observed MW: 115 kDa
FAQs
我们一般不推荐客户回收利用抗体。 因为抗体使用之后缓冲体系已经发生改变,不同客户在回收抗体的保存条件上也会有差异,所以抗体回收使用效果无法保证。另外,我们对一批抗体回收验证测试,测试结果显示不同抗体可回收次数不同,一般效价越高的抗体,可重复使用的次数越多,客户可根据实验情况来确定







评论(0)